We Address Unmet Medical Needs to Improve Patient Outcomes and Quality of Life
The product portfolio is led by already launched Binosto® for the treatment of postmenopausal osteoporosis.
Partnering with Us
Our strategy relies on partnerships for shared commercial success. We welcome you to find out more about partnering.
EffRx Pharmaceuticals participated in the BIO International Convention from June 4-7, 2018 in Boston